ABI-1968

DRUG2 trials

Sponsors

Antiva Biosciences

Conditions

Anal CancerAnus NeoplasmsCINCervical CancerCervical DysplasiaCervical Intraepithelial NeoplasiaCervical NeoplasmHIV Infection

Phase 1

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

CompletedNCT03202992

Antiva BiosciencesAnal Cancer, Anus Neoplasms, HIV Infection +2

Start: 2017-08-11End: 2019-02-04Updated: 2019-02-07

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection

CompletedNCT03239223

Antiva BiosciencesCervical Cancer, Cervical Dysplasia, Cervical Intraepithelial Neoplasia +7

Start: 2018-01-01End: 2018-10-30Updated: 2019-07-10